October 16, 2025

New Criteria, New Numbers on Obesity

A Lancet Commission definition integrating BMI with anthropometric measures increased obesity prevalence by ~60% in a major US cohort, identifying previously unrecognized high-risk patients while introducing distinct clinical phenotypes.

Conexiant

October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 15, 2025

How Hiring One Optometrist Unlocked £60k a Month in Stalled Revenue

Diagnosing the real bottleneck turned a hiring decision into a £60k/month growth lever

The Ophthalmologist

October 14, 2025

Osimertinib Plus Chemotherapy Significantly Prolongs Overall Survival in EGFR-Mutated Advanced NSCLC

The combination of the EGFR-targeting tyrosine kinase inhibitor osimertinib with platinum-based chemotherapy significantly improved overall survival as a first-line treatment for patients with EGFR-mu...

The ASCO Post

October 10, 2025

FDA Broadens Label for Schizophrenia Drug

The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder.

Conexiant

October 10, 2025

Adolescent and Adult VTE After Arthroscopy Compared in Study

Lower venous thromboembolism risk is shown in adolescents than adults after knee arthroscopy, but comorbidities like diabetes and obesity raise risk.

Conexiant

October 09, 2025

Is Postoperative AF Changing Anticoagulation Decisions?

Cohort of 198 coronary artery bypass grafting patients monitored for 1 year with insertable cardiac devices found high incidence of new-onset atrial fibrillation but minimal late burden.

Conexiant

October 08, 2025

Contemporary Management of Chronic Myeloid Leukemia, According to Hagop M. Kantarjian, MD, FASCO

Chronic myeloid leukemia (CML) is one of the success stories among the hematologic malignancies. Now, with decades of data informing its management, it is time to change some of the practices to which...

The ASCO Post

October 07, 2025

EASO Issues Obesity Pharmacotherapy Guidance

EASO framework guides obesity drug selection by weight loss effect and complication focus.

Conexiant